You are here

  • Home
  • Archive
  • Volume 73, Issue 1
  • Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis

Authors

  1. Correspondence to Dr LA Trouw, Department of Rheumatology, C1-R, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands; L.A.Trouw{at}lumc.nl.
View Full Text

Citation

Suwannalai P, Britsemmer K, Knevel R, et al
Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis
Annals of the Rheumatic Diseases 2014;73:270-276.

Publication history

  • Received September 4, 2012
  • Revised December 18, 2012
  • Accepted February 7, 2013
  • First published March 5, 2013.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions